Finance

Lists
56F:FRA
Exact Therapeutics AS
€0.032
+16.36%
(+0.0045) 1D
Sep 4, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 56F...
Open
€0.03
High
€0.03
Low
€0.03
Volume
0.00
52-wk high
€0.20
52-wk low
€0.02
No. of employees
11
Open
€0.03
High
€0.03
Low
€0.03
Volume
0.00
52-wk high
€0.20
52-wk low
€0.02
No. of employees
11
News stories
From web sources and news partners
About Exact Therapeutics AS
CEO-
Employees11
Founded2012
Headquarters-
SectorBiotechnology
Websiteexact-tx.com
Previous reportsAll values in NOK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in NOK
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
29.50K
29.50K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
20.27M
20.27M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.12M
8.12M
6.37M
6.37M
Operating expense
22.93M
22.93M
19.54M
19.54M
Total operating expenses
22.93M
22.93M
19.54M
19.54M
Operating income
-22.93M
-22.93M
-19.51M
-19.51M
Other non operating income
6.92K
6.92K
-1.48K
-1.48K
EBT including unusual items
-24.59M
-24.59M
-18.90M
-18.90M
EBT excluding unusual items
-24.59M
-24.59M
-18.90M
-18.90M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
14.12M
14.12M
-8.25M
-8.25M
Net income
-24.59M
-24.59M
-18.90M
-18.90M
Net profit margin
-
-
-64,059.72%
-64,059.72%
Earnings per share
-
-
-
-
Interest and investment income
824.03K
824.03K
484.64K
484.64K
Interest expense
-8.34K
-8.34K
-9.10K
-9.10K
Net interest expenses
815.69K
815.69K
475.53K
475.53K
Depreciation and amortization charges
690.73K
690.73K
1.15M
1.15M
EBITDA
-22.36M
-22.36M
-18.54M
-18.54M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps